Active	Status	Sponsor type	Region	Phase	Filter
8 Active 4 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lewis, Joanne
ACTION, NCT05580562: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the Study) Jan 2026 - Dec 2026: Final data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma Jan 2025 - Mar 2025: Interim data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma	Recruiting	3	450	Europe, Canada, Japan, US, RoW	Dordaviprone (ONC201), Dordaviprone (ONC201) + Placebo, Placebo	Chimerix	H3 K27M, Glioma	08/26	08/26
CLINGLIO, NCT04250922 / 2018-000365-37: LAM561 With RT and TMZ for Adults With Glioblastoma	Active, not recruiting	2/3	140	Europe, RoW	LAM561, TMZ, RT	Laminar Pharmaceuticals, Laboratory Corporation of America, Northern Institute for Cancer Research, Newcastle, Theradis pharma, LIPODOM THERAPEUTICS	Primary Glioblastoma, Glioblastoma Multiforme	10/24	05/25
NCT04359745: Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression	Recruiting	N/A	500	Europe		Guy's and St Thomas' NHS Foundation Trust, King's College London	Glioblastoma	05/24	05/25
NCT04274283: Tessa Jowell BRAIN MATRIX - Platform Study	Recruiting	N/A	1000	Europe	Matched Tumour and Blood Sample - Research Pathway, Matched Tumour and Blood Sample - NHS GMS pathway	University of Birmingham, The Brain Tumour Charity, University of Oxford, University of Edinburgh, Genomics England	Glioma	03/26	03/27
Zaman, Azfar
NCT06412250: A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)	Recruiting	N/A	2000	Europe, RoW		Translumina Therapeutics LLP, Iqvia Pty Ltd	Cardiovascular Diseases	05/26	05/26
ZODIAC, NCT05844566: OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.	Active, not recruiting	N/A	1584	Europe	Decision Support System (DSS)	Imperial College London, Sanofi, Axtria, Inc.	Acute Coronary Syndrome, Myocardial Infarction	11/24	11/24
NCT04390672: Multivessel TALENT	Active, not recruiting	N/A	1550	Europe	SUPRAFLEX Cruz, SYNERGY	National University of Ireland, Galway, Ireland	Coronary Artery Disease, Myocardial Ischemia, Coronary Disease, Heart Diseases, Cardiovascular Diseases, Arterial Occlusive Diseases, Vascular Diseases	09/25	09/26
OPTIMAL, NCT04111770: The Randomized Controlled Trial	Active, not recruiting	N/A	807	Europe	IVUS guided Percutaneous Coronary Intervention, QCA guided Percutaneous Coronary Intervention	ECRI bv, Philips Healthcare, Boston Scientific Corporation	Left Main Coronary Artery Stenosis	07/25	07/25